Delivery Order SPE2DB20D3103-SPE2DB25FQ4N1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,885.09 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-unit package) on September 2, 2025, with completion scheduled for September 3, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,082.94 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-pack units) on September 10, 2025, with completion scheduled for September 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,145.59 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for Xulane 150-35 mcg/day contraceptive patches (quantity of 3). This contract is a firm fixed price delivery order with an ultimate completion date of August 20, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a primary pharmaceutical distributor for federal medical procurement needs,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for Xulane 150-35 mcg/day contraceptive patches (3-pack units) with a ceiling value of $1,053.04. This delivery order, which carries a firm fixed price structure and no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The ultimate completion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches on September 5, 2025, with a ceiling value of $3,164.04 under a firm fixed-price contract type. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The place of performance is located in...
- The Defense Logistics Agency awarded a $5,940.28 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Xulane 150-35 mcg/day contraceptive patches (quantity: 3 units). This competitively awarded, firm fixed-price delivery order is not set-aside and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 26, 2025. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,150.91 firm fixed price delivery order to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count) on September 26, 2025, with completion targeted for September 29, 2025. This non-set-aside competitive award was issued from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, supporting federal medical procurement requirements for military and veteran healthcare systems. The delivery order represents a child...
- The Defense Logistics Agency awarded a $1,719.90 delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of Xulane 150-35 mcg/day contraceptive patches (3-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 15, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger prime indefinite...
- The Defense Logistics Agency awarded a $2,948.40 delivery order to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-month supply) on September 26, 2025, with completion targeted for September 29, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $11,136.91 for Xulane 150-35 mcg/day contraceptive patches (3-count units) on July 2, 2025, with an ultimate completion date of July 3, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ4N1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,931.20 to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Xulane 150-35 mcg/day contraceptive patches (3-unit quantity). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 25, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which carries a $999,999,999.00 ceiling value and extends through December 2026. Performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant portfolio of federal medical procurement contracts with the Defense Logistics Agency, supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems. The company's SPE2DX contract vehicle serves as a global pharmaceutical support mechanism enabling the delivery of specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. This delivery order for Xulane contraceptive patches reflects the company's ongoing role in fulfilling routine medical supply needs within the DLA's broader pharmaceutical procurement strategy.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 9/24/25 |